Afuco™ Anti-Human HAMP ADCC Therapeutic Antibody (LY2787106), ADCC Enhanced
Anti-HAMP ADCC Enhanced Antibody (LY2787106) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a fully humanized antibody againsts hepcidin currently in phase I human trials for cancer-related anemia.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-324CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | HAMP |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Open under aseptic conditions. |